Main oncological aspects of the diagnosis of precancerous diseases and early stages of endometrial, cervical and ovarian malignancies


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Prevention and early diagnosis of reproductive tract malignancies are one of the most important socio-medical tasks, which depends mainly on physicians’ cancer awareness and is necessary to develop an effective patient management strategy. Of greatest importance are the development and implementation of effective screening programs focused on the detection of early-stage cancers, often at an asymptomatic stage, in a practically healthy target population. These measures are aimed at cancer risk reduction, detection of early disease, and improvement in treatment strategies. Oncological preventive activities should include strengthening physicians’ cancer awareness, availability of primary care and diagnostic tests, clear patient referral guidelines, coordinating care, and timely appropriate treatment. The cancer care system is effective only if all these stages are accessible and consistent.

Full Text

Restricted Access

About the authors

O. E Lavrinovich

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: olgalav1973@mail.ru

O. A Smirnova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: ssmirnova.oa@gmail.com

I. E Meshkova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: meshkova.62@bk.ru

E. A Ul’rikh

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia; Mechnikov North-Western State Medical University of Minzdrav of Russia

Email: elenaulrikh@yandex.ru

N. A Mikaya

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: nmikaya@mail.ru

M. G Yakovleva

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: mersend@mail.ru

N. E Bondarev

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: oncl@rion.spb.ru

A. V Abramova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: oncl@rion.spb.ru

Z. N Ibragimov

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: oncl@rion.spb.ru

R. M Beibulatova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: rita.beibulatova@mail.ru

E. A Nekrasova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: ekaterina_neks@mail.ru

T. V Gorodnova

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

A. A Mikhet’ko

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: amikhetko@mail.ru

A. F Urmancheeva

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia; Mechnikov North-Western State Medical University of Minzdrav of Russia

Email: adaurm@mail.ru

I. V Berlev

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: iberlev@gmail.com

A. M Belyaev

Petrov National Medical Research Center of Oncology of MMinzdrav of Russia

Email: oncl@rion.spb.ru

References

  1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) М.: МНИОИ им. П.А. Герцена филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2018. 250 с.
  2. Emons G., Beckmann M.W., Schmidt D., Mallmann P. New WHO classification of endometrial hyperplasias. Geburtsh. Frauenheilk. 2015; 75: 135-6.
  3. Royal College of Obstetricians and Gynaecologists - RCOG. Management of Endometrial Hyperplasia. RCOG/BSGE Green-top Guideline No. 67. February 2016.
  4. Уварова Е.В. Сочетанная патология эндо- и миометрия у больных репродуктивного возраста (вопросы патогенеза, диагностики и лечения): дисс. д-ра мед. наук. М.; 1993. 127 с.
  5. Харенкова E.Л. Прогноз и профилактика гиперпластических процессов эндометрия в менопаузе: дисс. канд. мед. наук. Иркутск; 2009. 23 с.
  6. Baak J.P., Mutter G.L., Robboy S., van Diest P.J., Uyterlinde A.M., Orbo A. et al. The molecular genetics and morphometry- based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005; 103(11): 2304-12. https://dx.doi.org/10.1002/ cncr.21058.
  7. Resnick K.E., Hampel H., Fishel R., Cohn D.E. Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol. Oncol. 2009; 114(1): 128-34. https://dx.doi.org/10.1016/j.ygyno.2009.03.003.
  8. Паяниди Ю.Г., Жорданиа К.И., Паукер В.,Сельчук В.Ю., Казубская Т.П. Первично-множественные злокачественные новообразования органов репродуктивной системы и толстой кишки у женщин. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2016; 27(2): 109-12.
  9. Бохман Я.В. Руководство по онкогинекологии. Монография. Л.: Медицина; 1989. 463 с.
  10. Сафронов А.В. Оценка сонографии и гистероскопии в диагностике опухолей гениталий у женщин с постменопаузальными кровотечениями: дисс. канд. мед. наук. Санкт-Петербург; 2004.
  11. Edris F., Vilos G.A., Al-Mubarak A., Ettler H.C., Hollett-Caines J., Abu-Rafea B. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia. J. Minim. Invasive Gynecol. 2007; 14(1): 68-73. https://dx.doi.org/10.1016/j.jmig.2006.08.007.
  12. Савельева Г.М., Бреусенко В.Г., Капушева Л.М. Гистероскопия: атлас и руководство. М.: ГЭОТАР-Медиа; 2017. 248 с.
  13. Taneja B.K., Arora R.P., Alam M. Role of hysteroscopy in diagnosis of menstrual discorders. Med. J. Armed. Forces India. 1996; 52(1): 15-8. https://dx.doi. org/10.1016/S0377-1237(17)30827-4.
  14. Попов А.А., Алиева А.С., Мананникова Т.Н., Барто Р.А. Сравнение различных методов абляции при гиперпластических процессах эндометрия. РМЖ Мать и дитя. 2017; 26: 1942-5.
  15. Feng Y.Z., Shiozawa T., Miyamoto T., Kashima H., Kurai M., Suzuki A., Konishi I. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Clin. Cancer Res. 2005; 11(17): 6133-8. https://dx.doi.org/10.1158/1078-0432.CCR-04-2670.
  16. Kudela M., Pilka R., Hejtmanek P., Dzyincuk P., Ondrova D. The importance of sonography and hysteroscopy at suspected findings on endometrium of menopausal women. CeskaHYPERLINK “https://www.ncbi.nlm. nih.gov/pubmed/18567430” HYPERLINK “https://www.ncbi.nlm.nih.gov/ pubmed/18567430”GynekolHYPERLINK “https://www.ncbi.nlm.nih.gov/ pubmed/18567430”. 2008; 73(2): 104-8.
  17. Trojano G., Damiani G.R., Casavola V.C., Loiacono R., Malvasi A., Pellegrino A. et al. The role of hysteroscopy in evaluating postmenopausal asymptomatic women with thickened endometrium. Gynecol. Minim. Invasive Ther. 2018; 7(1): 6-9. https://dx.doi.org/10.4103/GMIT.GMIT_10_17.
  18. Polyzos N.P., Mauri D., Tsioras S., Messini C.I., Valachis A., Messinis I.E. Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis. Int. J. Gynecol. Cancer. 2010; 20(2): 261-7. https://dx.doi.org/10.1111/igc.0b013e3181ca2290.
  19. Tempfer C.B., Froese G., Buerkle B., Polterauer S., Grimm C., Concin N. et al. Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trial. Exp. Ther. Med. 2011; 2(5): 991-5. https://dx.doi.org/10.3892/etm.2011.309.
  20. Wiebea E., Denny L., Thomas G. Cancer of the cervix uteri. Figo cancer report. Int. J. Gynecol. Obstet. 2012; 119(Suppl. 2): S100-9. https://dx.doi. org/10.1016/S0020-7292(12)60023-X.
  21. Ayman Al-Talib, Farr Nezhat, Togas Tulandi. Cite as. The role of hysteroscopy in diagnosis and management of endometrial cancer. Gynecol. Surg. 2010; 7(3): 211-6. https://dx.doi.org/10.1007/s10397-010-0604-1.
  22. Mencaglia L. Hysteroscopy and adenocarcinoma. ObstetHYPERLINK “https://www.ncbi.nlm.nih.gov/pubmed/8524538”.HYPERLINK “https:// www.ncbi.nlm.nih.gov/pubmed/8524538” GynecolHYPERLINK “https:// www.ncbi.nlm.nih.gov/pubmed/8524538”. HYPERLINK “https://www. ncbi.nlm.nih.gov/pubmed/8524538”ClinHYPERLINK “https://www. ncbi.nlm.nih.gov/pubmed/8524538”. HYPERLINK “https://www.ncbi. nlm.nih.gov/pubmed/8524538 ”NorthHYPERLINK “https://www.ncbi. nlm.nih.gov/pubmed/8524538” HYPERLINK “https://www.ncbi.nlm.nih. gov/pubmed/8524538”AmHYPERLINK “https://www.ncbi.nlm.nih.gov/ pubmed/8524538”. 1995; 22(3): 573-9.
  23. Киселев В.И. Вирусы папилломы человека в развитии рака шейки матки. М.; 2004. 179 с.
  24. Роговская С.И., Липова Е.В. Шейка матки, влагалище, вульва. Физиология, патология, кольпоскопия, эстетическая коррекция. Руководство для практикующих врачей. 2-е изд. М.: Медиабюро «Статус презенс»; 2016.
  25. Altobelli E., Scarselli G., Lattanzi A., Fortunato C., Profeta V.F. A comparison between Pap and HPV screening tests and screening methods. Mol. Clin. Oncol. 2016; 5(2): 348-54. https://dx.doi.org/10.3892/mco.2016.909.
  26. Chen K., Ouyang Y., Hillemanns P., Jentschke M. Excellent analytical and clinical performance of a dry self-sampling device for human papillo- mavirus detection in an urban Chinese referral population. J. Obstet. Gynaecol. Res. 2016; 42(12): 1839-45. https://dx.doi.org/10.1111/jog.13132.
  27. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014; 383(9916): 524-32. https://dx.doi.org/10.1016/S0140-6736(13)62218-7.
  28. Tjalma W.A. The ideal cervical cancer screening recommendation for Belgium, an industrialized country in Europe. Eur. J. Gynaecol. Oncol. 2014; 35(3): 211-8. https://dx.doi.org/10.1016/j.cmi.2017.05.020.
  29. Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J. et al. American Cancer Society, Amercan Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 2012; 137(4): 516-42. https://dx.doi.org/10.1309/AJCPTGD94EVRSJCG.
  30. World Health Organization. Guidelines for screening and treatment of precan-cerous lesions for cervical cancer prevention. WHO guidelines. WHO; 2013.
  31. Underwood M., Arbyn M., Parry Smith W., De BellisAyres S., Todd R., Redman C. W. et al. Accuracy of colposcopydirected punch biopsies: a systematic review and metaanalysis. BJOG. 2012; 119(11): 1293-301. https://dx.doi. org/10.1111/j.1471-0528.2012.03444.x.
  32. Jeronimo J., Schiffman M. Colposcopy at a crossroads. Am. J. Obstet. Gynecol. 2006; 195(2): 349-53. https://dx.doi.org/10.1016/j.ajog.2006.01.091.
  33. Nayar R., Wilbur D.C. The Pap Test and Bethesda 2014. “The reports of my demise have been greatly exaggerated” (after a quotation from Mark Twain). Acta Cytol. 2015; 59(2): 121-32. https://dx.doi.org/10.1159/000381842.
  34. Wei M.K. Pathology of eervical earcinoma. The Global Library оf Women’s Medicine. 2017.
  35. El-Nashar S.A., Shazly S.A., Hopkins M.R., Bakkum-Gamez J.N., Famuyide A.O. Loop electrosurgical excision procedure instead of cold-knife conization for cervical intraepithelial neoplasia in women with unsatisfactory colposcopic examinations: a systematic review and meta-analysis. J. Low. Genit. Tract Dis. 2017; 21(2): 129-36. https://dx.doi.org/10.1097/LGT.0000000000000287.
  36. Jiang Y., Chen C., Li L. Comparison of cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ (ACIS): a systematic review and meta-analysis. PLoS One. 2017; 12(1): e0170587. https://dx.doi. org/10.1371/journal.pone.0170587.
  37. Hasegawa K., Torii Y., Kato R., Udagawa Y., Fukasawa I. The problems of cervical conization for postmenopausal patients. Eur. J. Gynaecol. Oncol. 2016; 37(3): 327-31.
  38. Cheng X., Feng Y., Wang X., Wan X., Xie X., Lu W. The effectiveness of conization treatment for post-menopausal women with high-grade cervical intraepithe-lial neoplasia Exp. Ther. Med. 2013; 5(1): 185-8. https://dx.doi.org/10.3892/ etm.2012.748.
  39. Морохов К.Ю., Нечушкина В.М., Кузнецов В.В. Актуальные вопросы хирургического лечения рака шейки матки. Практическая онкология. 2009; 10(2): 93-101.
  40. Кравец А., Кузнецов В.В., Морхов К.Ю., Нечушкина В.М., Хохлова С.В. Клинические рекомендации по диагностике и лечению рака шейки матки. М.: Ассоциация онкологов России; 2014.
  41. Kobak W.H., Roman L.D., Felix J.C., Muderspach L.I., Schlaerth J.B., Morrow C.P. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet. Gynecol. 1995; 85(2): 197-201.
  42. Сидорук А.А. Клинико-морфологические особенности и проблемы диагностики аденогенных карцином in situ шейки матки: дисс. канд. мед. наук. Санкт-Петербург; 2009.
  43. Pirtea L., Grigora§ D., Matusz P., Pirtea M., Moleriu L., Tudor A. et al. Human papilloma virus persistence after cone excision in women with cervical high grade squamous intraepithelial lesion: a prospective study. Can. J. Infect. Dis. Med. Microbiol. 2016; 2016: 3076380. https://dx.doi.org/10.1155/2016/3076380.
  44. Tierney K.E., Lin P.S., Amezcua C., Koji Matsuo, Wei Ye, Felix J.C., Roman L.D. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am. J. Obstet. Gynecol. 2014; 210(4): 366. e5.
  45. Luna J., Plata M., Gonzalez M., Correa A., Maldonado I., Nossa C. et al. Longterm follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil in adult women. PLoS One. 2013; 8(12): e8343. https://dx.doi. org/10.1371/journal.pone.0083431.
  46. Бахидзе Е.В., Берлев И.В., Архангельская А.П., Малек А.В. Возможности оценки прогноза развития преинвазивных неоплазий шейки матки с помощью новейших молекулярно-биологических методов. Вопросы онкологии. 2016; 62(3): 397-400.
  47. Lee J.W., Choi C.H., Choi J.J., Park Y.A., Kim S.J., Hwang S.Y. et al. Altered MicroRNA expression in cervical carcinomas. Clin. Cancer Res. 2008; 14: 2535-42. https://dx.doi.org/10.1158/1078-0432.CCR-07-1231.
  48. Wang F., Li Y., Zhou J., Xu J., Peng C., Ye F. et al. miR-375 isdown regulated insquamous cervical cancer and inhibits cell migration and invasion iatargeting transcription factor SP1. Am. J. Pathol. 2011; 179(5): 2580-8. https://dx.doi. org/10.1016/j.ajpath.2011.07.037.
  49. Никогосян С.О., Каирбаеа М.Ж., Козаченко В.П., Жорданиа К.И., Кузнецов В.В. Хирургическое лечение рака яичников. В. кн.: Горбунова В.А., ред. Диагностика и лечение рака яичников. М.; 2011: 87-117.
  50. Bast RC. Jr. Status of tumor markers in ovarian cancer screening. J. Clin. Oncol. 2003; 21: 200-5.
  51. Bast R.C. Jr. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare. Trans. Am. Clin. Climatol. Assoc. 2004; 115: 233-48.
  52. Клинико-лабораторная концепция исследования серологических опухолеассоциированных маркеров и некоторых гормонов у онкологических больных. М.: «МНИОИ им. П.А. Герцена» - филиал ФГБУ «НМИРЦ» Минздрава России; 2016.10 с.
  53. Чибисов а Г.М., Хабаров С. В. Комплексное определение онкомаркеров СА125, НЕ1 и индекса ROMA, как фактор прогноза развития рака яичников. Вестник новых медицинских технологий. 2018; 25(3): 15-20.
  54. Подзолкова Н.М., Львова А.Г., Зубарев А.Р., Осадчев В.Б. Дифференциальная диагностика опухолей и опухолевидных образований яичников: клиническое значение трехмерной эхографии. Вопросы гинекологии, акушерства и перинатологии. 2009; 8(1): 7-16.
  55. Delorme S., Knopp M.V. Non-invasive vascular imaging: assessing tumour vascularity. Eur. Radiol. 1998; 8(4): 517-27. https://dx.doi.org/0.1007/ s003300050428.
  56. Claudon M., Cosgrove D., Albrecht T., Bolondi L., Bosio M., Calliada F. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008; 29(1): 28-44. https://dx.doi.org/10.1055/s-2007-963785.
  57. Irvine T., Wanitkun S., Powers J., Shiota T., Kenny A., Sahn D.J. Acoustically stimulated transient power scattering explains enhanced detection of the very low velocities in myocardial capillaries by power Doppler imaging: an in vitro study. J. Am. Soc. Echocardiogr. 1999; 12(8): 643-9. https://dx.doi.org/10.1053/ je.1999.v12.a99067.
  58. Урманчеева А.Ф., Мешкова И.Е. Вопросы эпидемиологии и диагностики рака яичников. Практическая онкология. 2000; 1(4): 7-13.
  59. Liu Z., Yang F., Zhang Y., Yu H., Zhu H., Yang R., Fan L. Conventional, Doppler and Contrast-Enhanced Ultrasonography in Differential Diagnosis of Ovarian Masses. Cell. Physiol. Biochem. 2016; 39(6): 2398-408. https://dx.doi. org/10.1159/000452508.
  60. Любченко Л.Н., Батенева Е.И. Медико-генетическое консультирование и ДНК-диагностика при наследственной предрасположенности к раку молочной железы и раку яичников. М.: ИГ РОНЦ; 2014. 75 с.
  61. Лаптиев С.А., Корженевская М.А., Соколенко А.П., Иевлева А.Г., Имянитов Е.Н. Медико-генетическое консультирование при наследственных формах рака молочной железы и рака яичников. Ученые записки СПбГМУ им. акад. И. П. Павлова. 2018; 25(2): 7-18.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies